Nancy Pelosi Is Crushing The S&P 500 And These Are Her 3 Best Positions

Photo of Rich Duprey
By Rich Duprey Updated Published

Key Points

  • Nvidia (NVDA) represents roughly 22% of Pelosi’s portfolio after she exercised 50 call options in early 2026, making it the crown jewel of her holdings. Tempus AI (TEM) fell 14% in the last two weeks following a Q1 2026 revenue miss, despite a $200 million AstraZeneca deal. Alphabet (GOOGL) and Amazon (AMZN) are now cornerstones of her 2026 outlook after she exercised call options in both companies.

  • Pelosi’s shift toward large-cap tech “safe havens” and away from speculative AI names reflects a broader market rotation as congressional stock trading faces fresh bipartisan scrutiny for potential ban legislation.

  • The analyst who called NVIDIA in 2010 just named his top 10 stocks and Broadcom wasn't one of them. Get them here FREE.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Nancy Pelosi Is Crushing The S&P 500 And These Are Her 3 Best Positions

© Alex Wong / Getty Images News via Getty Images

Warren Buffett may be considered the greatest investor of our time, but even he can’t touch the prowess of California congresswoman Nancy Pelosi (D-CA). Over the past decade, Pelosi has generated a cumulative return of 816% from her investments. As of May 2026, her estimated net worth has climbed to approximately **$649.7 million**, maintaining a dominant 87% win rate across her trades.

In contrast, the Oracle of Omaha has managed a 282% cumulative return for Berkshire Hathaway (NYSE:BRK-A | BRK-A Price Prediction)(NYSE:BRK-B) during that same period. While Buffett remains a benchmark for many, in the realm of raw percentage gains, the “Pelosi Portfolio” continues to set a pace that is difficult to match.

Congress’s Elite Market Timers

Pelosi isn’t the only politician with uncanny market timing. While she generated returns in excess of 70% in 2024, she was actually the 10th best congressional investor that year. According to Unusual Whales, which tracks politician trades, leaders like Rep. David Rouzer (R-NC) and Rep. Debbie Wasserman Schultz (D-FL) posted even higher returns of 149% and 142.3%, respectively.

The ongoing scrutiny over these gains has reached a new fever pitch. On May 12, 2026, a bipartisan group of lawmakers led by Krishnamoorthi and Cloud launched a fresh push to finally include a ban on congressional stock trading within the House rules package, signaling a potential shift in the regulatory landscape.

Pelosi’s 2026 Strategy Shift

While her “prescient” tech trades—such as selling Microsoft (NASDAQ:MSFT) and Visa (NYSE:V) just before regulatory actions—are well-documented, her recent moves suggest a broader strategy. In January 2026, Pelosi made a significant pivot into high-yield financials by purchasing 25,000 shares of **AllianceBernstein**. She also recently exercised call options for both Alphabet and Amazon, doubling down on Big Tech even as the market shifts focus toward memory specialists like Micron.

Nvidia (NVDA)

Nvidia remains the crown jewel of Pelosi’s holdings, representing roughly 22% of her total portfolio. In early 2026, she further solidified this position by exercising 50 call options. Having ridden the stock through its 10-for-1 split and subsequent AI-driven rallies, her conviction in the chipmaker remains the primary driver of her market-beating performance.

Alphabet (GOOGL) / Amazon (AMZN)

Replacing the earlier speculative focus on smaller AI outfits, Pelosi’s heavy exercise of options in Alphabet and Amazon has become a cornerstone of her 2026 outlook. These moves suggest a flight to “Safe Haven” tech giants that provide stability and recurring revenue, acting as a hedge against more volatile semiconductor holdings.

Tempus AI (TEM)

While Tempus AI was Pelosi’s breakout trade of 2025, the narrative has cooled in mid-2026. After a revenue miss in Q1 2026, the stock has seen a 14% decline in the last two weeks. Despite the $200 million deal with AstraZeneca (NYSE:AZN) that initially drove gains, analysts now maintain a cautious “Hold” as the healthcare AI sector faces increased valuation scrutiny.


Photo of Rich Duprey
About the Author Rich Duprey →

After two decades of patrolling the dark corners of suburbia as a police officer, Rich Duprey hung up his badge and gun to begin writing full time about stocks and investing. For the past 20 years he’s been cruising the markets looking for companies to lock up as long-term holdings in a portfolio while writing extensively on the broad sectors of consumer goods, technology, and industrials. Because his experience isn’t from the typical financial analyst track, Rich is able to break down complex topics into understandable and useful action points for the average investor. His writings have appeared on The Motley Fool, InvestorPlace, Yahoo! Finance, and Money Morning. He has been featured in both U.S. and international publications, including MarketWatch, Financial Times, Forbes, Fast Company, and USA Today.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

ZBRA Vol: 2,879,381
HUM Vol: 2,904,415
CNC Vol: 9,427,268
ZBH Vol: 2,434,903

Top Losing Stocks

QCOM Vol: 38,596,346
CTRA Vol: 73,319,495
CZR Vol: 6,562,058
INTC Vol: 173,818,366
SWKS Vol: 7,019,097